Challenging pedigrees seen in a hereditary cancer consultation center

Henry T. Lynch, Susan T. Tinley, Jane F. Lynch, Thomas M. Attard

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The clinical translation of the significance of cancer "running in families" has become a source of major contention as a result of the explosion of knowledge about cancer causality at the molecular level. At the clinical level, the increasing awareness of the familial and hereditary burden of cancer has contributed heavily to both physician and lay concern about cancer risk. Problems in interpretation of the significance of a cancer family history may arise due to a variety of factors, and even if the physician correctly diagnoses a hereditary cancer-predisposing syndrome there may still be barriers to patient compliance with surveillance and management recommendations. Our purpose is to discuss a variety of potential barriers in the diagnosis and management of patients at increased hereditary cancer risk, drawing on examples from a cohort of ∼300 families evaluated at Creighton University's Hereditary Cancer Consultation Center over 8 years. Each case was selected because of the presence of one or more clinical, pathologic, molecular genetic, psychosocial, economic, confidentiality, or insurance or employment discrimination factors that had the potential to pose an obstacle in diagnosis or in patient compliance with screening and management recommendations.

Original languageEnglish
Pages (from-to)91-101
Number of pages11
JournalCancer Genetics and Cytogenetics
Volume153
Issue number2
DOIs
StatePublished - Sep 2004

Fingerprint

Pedigree
Referral and Consultation
Neoplasms
Patient Compliance
Hereditary Neoplastic Syndromes
Physicians
Explosions
Confidentiality
Insurance
Causality
Molecular Biology
Economics

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Challenging pedigrees seen in a hereditary cancer consultation center. / Lynch, Henry T.; Tinley, Susan T.; Lynch, Jane F.; Attard, Thomas M.

In: Cancer Genetics and Cytogenetics, Vol. 153, No. 2, 09.2004, p. 91-101.

Research output: Contribution to journalArticle

Lynch, Henry T. ; Tinley, Susan T. ; Lynch, Jane F. ; Attard, Thomas M. / Challenging pedigrees seen in a hereditary cancer consultation center. In: Cancer Genetics and Cytogenetics. 2004 ; Vol. 153, No. 2. pp. 91-101.
@article{e13220a157164e2ab2acf7719061728b,
title = "Challenging pedigrees seen in a hereditary cancer consultation center",
abstract = "The clinical translation of the significance of cancer {"}running in families{"} has become a source of major contention as a result of the explosion of knowledge about cancer causality at the molecular level. At the clinical level, the increasing awareness of the familial and hereditary burden of cancer has contributed heavily to both physician and lay concern about cancer risk. Problems in interpretation of the significance of a cancer family history may arise due to a variety of factors, and even if the physician correctly diagnoses a hereditary cancer-predisposing syndrome there may still be barriers to patient compliance with surveillance and management recommendations. Our purpose is to discuss a variety of potential barriers in the diagnosis and management of patients at increased hereditary cancer risk, drawing on examples from a cohort of ∼300 families evaluated at Creighton University's Hereditary Cancer Consultation Center over 8 years. Each case was selected because of the presence of one or more clinical, pathologic, molecular genetic, psychosocial, economic, confidentiality, or insurance or employment discrimination factors that had the potential to pose an obstacle in diagnosis or in patient compliance with screening and management recommendations.",
author = "Lynch, {Henry T.} and Tinley, {Susan T.} and Lynch, {Jane F.} and Attard, {Thomas M.}",
year = "2004",
month = "9",
doi = "10.1016/j.cancergencyto.2004.01.011",
language = "English",
volume = "153",
pages = "91--101",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Challenging pedigrees seen in a hereditary cancer consultation center

AU - Lynch, Henry T.

AU - Tinley, Susan T.

AU - Lynch, Jane F.

AU - Attard, Thomas M.

PY - 2004/9

Y1 - 2004/9

N2 - The clinical translation of the significance of cancer "running in families" has become a source of major contention as a result of the explosion of knowledge about cancer causality at the molecular level. At the clinical level, the increasing awareness of the familial and hereditary burden of cancer has contributed heavily to both physician and lay concern about cancer risk. Problems in interpretation of the significance of a cancer family history may arise due to a variety of factors, and even if the physician correctly diagnoses a hereditary cancer-predisposing syndrome there may still be barriers to patient compliance with surveillance and management recommendations. Our purpose is to discuss a variety of potential barriers in the diagnosis and management of patients at increased hereditary cancer risk, drawing on examples from a cohort of ∼300 families evaluated at Creighton University's Hereditary Cancer Consultation Center over 8 years. Each case was selected because of the presence of one or more clinical, pathologic, molecular genetic, psychosocial, economic, confidentiality, or insurance or employment discrimination factors that had the potential to pose an obstacle in diagnosis or in patient compliance with screening and management recommendations.

AB - The clinical translation of the significance of cancer "running in families" has become a source of major contention as a result of the explosion of knowledge about cancer causality at the molecular level. At the clinical level, the increasing awareness of the familial and hereditary burden of cancer has contributed heavily to both physician and lay concern about cancer risk. Problems in interpretation of the significance of a cancer family history may arise due to a variety of factors, and even if the physician correctly diagnoses a hereditary cancer-predisposing syndrome there may still be barriers to patient compliance with surveillance and management recommendations. Our purpose is to discuss a variety of potential barriers in the diagnosis and management of patients at increased hereditary cancer risk, drawing on examples from a cohort of ∼300 families evaluated at Creighton University's Hereditary Cancer Consultation Center over 8 years. Each case was selected because of the presence of one or more clinical, pathologic, molecular genetic, psychosocial, economic, confidentiality, or insurance or employment discrimination factors that had the potential to pose an obstacle in diagnosis or in patient compliance with screening and management recommendations.

UR - http://www.scopus.com/inward/record.url?scp=9944256937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9944256937&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2004.01.011

DO - 10.1016/j.cancergencyto.2004.01.011

M3 - Article

VL - 153

SP - 91

EP - 101

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 2

ER -